Biotechnology in Japan - 麻豆原创 Summary, Competitive Analysis and Forecast to 2025
Summary
Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Japanese biotechnology market had total revenues of $42.7bn in 2020, representing a compound annual growth rate (CAGR) of 4% between 2016 and 2020.
- The environment and industrial processing segment was the market's most lucrative in 2020, with total revenues of $16.6bn, equivalent to 38.9% of the market's overall value.
- Biotech plays a major role in Japan鈥檚 environmental targets, which are among the most stringent in the world, and will continue to drive growth in the market.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan
- Leading company profiles reveal details of key biotechnology market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts
Reasons to Buy
- What was the size of the Japan biotechnology market by value in 2020?
- What will be the size of the Japan biotechnology market in 2025?
- What factors are affecting the strength of competition in the Japan biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's biotechnology market?
Table of Contents
1 Executive Summary
1.1. 麻豆原创 value
1.2. 麻豆原创 value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. 麻豆原创 rivalry
1.6. Competitive Landscape
2 麻豆原创 Overview
2.1. 麻豆原创 definition
2.2. 麻豆原创 analysis
3 麻豆原创 Data
3.1. 麻豆原创 value
4 麻豆原创 Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 麻豆原创 Outlook
5.1. 麻豆原创 value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
7.4. Are there any notable threats to leading players in this market?
7.5. How might the COVID-19 pandemic affect the competitive landscape?
8 Company Profiles
8.1. Takeda Pharmaceutical Company Limited
8.2. Astellas Pharma Inc.
8.3. Daiichi Sankyo Co Ltd
8.4. Mitsubishi Tanabe Pharma Corporation
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related 麻豆原创Line research
10.4. About 麻豆原创Line
List of Tables
List of Tables
Table 1: Japan biotechnology industry value: $ billion, 2016-20
Table 2: Japan biotechnology industry category segmentation: $ billion, 2020
Table 3: Japan biotechnology industry geography segmentation: $ billion, 2020
Table 4: Japan biotechnology industry value forecast: $ billion, 2020-25
Table 5: Takeda Pharmaceutical Company Limited: key facts
Table 6: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 8: Takeda Pharmaceutical Company Limited: Key Employees
Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 10: Astellas Pharma Inc.: key facts
Table 11: Astellas Pharma Inc.: Annual Financial Ratios
Table 12: Astellas Pharma Inc.: Key Employees
Table 13: Astellas Pharma Inc.: Key Employees Continued
Table 14: Daiichi Sankyo Co Ltd: key facts
Table 15: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 16: Daiichi Sankyo Co Ltd: Key Employees
Table 17: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 18: Mitsubishi Tanabe Pharma Corporation: key facts
Table 19: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 20: Japan size of population (million), 2016-20
Table 21: Japan gdp (constant 2005 prices, $ billion), 2016-20
Table 22: Japan gdp (current prices, $ billion), 2016-20
Table 23: Japan inflation, 2016-20
Table 24: Japan consumer price index (absolute), 2016-20
Table 25: Japan exchange rate, 2016-20
List of Figures
List of Figures
Figure 1: Japan biotechnology industry value: $ billion, 2016-20
Figure 2: Japan biotechnology industry category segmentation: % share, by value, 2020
Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: Japan biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the biotechnology industry in Japan, 2020
Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2020
Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2020
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2020
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2020
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2020
Takeda Pharmaceutical Company Limited
Astellas Pharma Inc.
Daiichi Sankyo Co Ltd
Mitsubishi Tanabe Pharma Corporation
听
听
*If Applicable.
